Sangamo Therapeutics
SGMO
#9864
Rank
NZ$94.31 M
Marketcap
NZ$0.23
Share price
-33.93%
Change (1 day)
-81.22%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$32.87 Million. In 2024 the company made an earning of -NZ$0.17 Billion, an increase over its 2023 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.19 Billion11.97%
2024 -NZ$0.17 Billion-17.27%
2023 -NZ$0.21 Billion-40.88%
2022 -NZ$0.35 Billion9.79%
2021 -NZ$0.32 Billion41.52%
2020 -NZ$0.23 Billion23.17%
2019 -NZ$0.19 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$96.63 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$80.33 Million75.62%
2014 -NZ$45.75 Million0.13%
2013 -NZ$45.69 Million
2011 -NZ$61.42 Million43.66%
2010 -NZ$42.75 Million28.52%
2009 -NZ$33.27 Million-23.55%
2008 -NZ$43.51 Million2.45%
2007 -NZ$42.47 Million19.5%
2006 -NZ$35.54 Million50.78%
2005 -NZ$23.57 Million75%
2004 -NZ$13.47 Million-33.25%
2003 -NZ$20.18 Million-62.27%
2002 -NZ$53.48 Million102.82%
2001 -NZ$26.37 Million23.21%
2000 -NZ$21.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$57.52 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.38 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.66 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$4.31 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.79 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.44 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.98 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.82 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA